Influence of 6q22-23 on overall survival in primary central nervous system lymphoma. Analysis of North Central Cancer Treatment Group trials 86 72 52, 93 73 51 and 96 73 51
- Citation:
- Br J Haematol vol 154 (1) 146-150
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- P50 CA108961, P50CA97274, P50CA108961-03S1, P50CA108961, P50 CA097274
- Corr. Author:
- Authors:
- Ellen R. McPhail Mark E. Law Paul A. Decker Brian P. O'Neill
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-86-72-52, NCCTG-937351, NCCTG-96-73-51
- Phases:
- 2
- Keywords:
- lymphomas, tumour suppressor, genes